Aveo, Astellas Report Positive Data from Phase III Comparative Tivozanib Trial in RCC - Genetic Engineering News

Earlier this month the firm reported preliminary data from an exploratory Phase II study comparing gefitinib monotherapy with gefitinib plus ficlatuzumab in previously untreated Asian patients with non-small cell lung cancer. This population has ...

UK Health Watchdog Backs Lung Cancer Drug From Roche - FOXBusiness

NICE, which has already recommended AstraZeneca PLC's (AZN.LN) Iressa, or gefitinib, for non-small-cell lung cancer, said that while there isn't any trial data directly comparing the two drugs, clinical specialists say the drugs are "very ...

Class Of Cancer Drugs Linked To Eye Infections, MHRA Warns - Newsinferno.com

Erbitux (cetuximab), Tarceva (erlotinib), Iressa (gefitinib) and Vectibix, are used to treat EGFR-expressing tumors. The cornea is covered with a layer of epithelium, which may become damaged when patients are receiving EGFR treatment.

Pivotal study on afatinib may challenge current standard first line treatment1 for lung cancer patients with EGFR mutations - Financial Post

Boehringer Ingelheim has initiated two further trials, LUX-Lung 7 and 8, to assess the potential benefit of afatinib* in a head-to-head comparison with erlotinib (in advanced squamous cell carcinoma of the lung) and gefitinib, respectively ...

Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 - Marketwatch

LUX-Lung 5, a global Phase III trial in patients previously treated with erlotinib or gefitinib. This is the first randomized Phase III trial investigating whether patients who initially benefit from treatment with afatinib alone may further ...

Seeing one in the many - star.com.my

If it is an adenocarcinoma (another kind of lung cancer) with a good activating mutation (what is called EGFR positive), we use either gefitinib or erlotinib. If it’s adenocarcinoma AKT positive, we use crizotinib. If it is adenocarcinoma negative for ...

Drug Eruptions - Medscape News

[Medline]. Graves JE, Jones BF, Lind AC, Heffernan MP. Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib. J Am Acad Dermatol. Aug 2006;55(2):349-53. [Medline]. Donovan JC, Ghazarian DM ...